Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate dose versus duration escalation in clomiphene-resistant polycystic ovarian disease
ACTRN12611000639921Phase 4Completed
- Sponsor
- Mervat Sheikh Elarab Elsedeek Omran
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clomiphene in polycystic ovary syndrome (PCOS) and anovulation (2 arms), sponsored by Mervat Sheikh Elarab Elsedeek Omran. Primary endpoint: Ovulation. Started Jan 2009; status: completed.
02
Drugs
clomiphene
03
Conditions
polycystic ovary syndrome (PCOS)anovulation
Beyond the preview
Go deeper on ACTRN12611000639921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000639921.